Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta

Abbott, 2010, Structure and function of the blood–brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030 Andras, 2005, Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells, J. Cereb. Blood Flow Metab., 25, 1159, 10.1038/sj.jcbfm.9600115 Aslam, 2012, TNF-alpha induced NFkappaB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells, Cytokine, 57, 269, 10.1016/j.cyto.2011.10.016 Bahadur, 2005, Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor, Mol. Cell. Endocrinol., 231, 1, 10.1016/j.mce.2004.12.007 Beato, 1995, Steroid hormone receptors: many actors in search of a plot, Cell, 83, 851, 10.1016/0092-8674(95)90201-5 Boggess, 2006, Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines, Gynecol. Oncol., 103, 417, 10.1016/j.ygyno.2006.03.032 Brouchet, 2001, Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta, Circulation, 103, 423, 10.1161/01.CIR.103.3.423 Burek, 2009, Cloning and characterization of the murine claudin-5 promoter, Mol. Cell. Endocrinol., 298, 19, 10.1016/j.mce.2008.09.041 Burek, 2010, Claudin-5 as a novel estrogen target in vascular endothelium, Arterioscler. Thromb. Vasc. Biol., 30, 298, 10.1161/ATVBAHA.109.197582 Burek, 2012, Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model, J. Vis. Exp., e4022 Campbell, 2012, Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury, Nat. Commun., 3, 849, 10.1038/ncomms1852 Darblade, 2002, Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor, Circ. Res., 90, 413, 10.1161/hh0402.105096 Deli, 2005, Permeability studies on in vitro blood–brain barrier models: physiology, pathology, and pharmacology, Cell. Mol. Neurobiol., 25, 59, 10.1007/s10571-004-1377-8 Dong, 1999, Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells, J. Biol. Chem., 274, 32099, 10.1074/jbc.274.45.32099 Errede, 2012, Blood–brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis, J. Neuropathol. Exp. Neurol., 71, 840, 10.1097/NEN.0b013e31826ac110 Fontijn, 2008, SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function, Am. J. Physiol. Heart Circ. Physiol., 294, H891, 10.1152/ajpheart.01248.2007 Forster, 2008, Tight junctions and the modulation of barrier function in disease, Histochem. Cell Biol., 130, 55, 10.1007/s00418-008-0424-9 Forster, 2005, Occludin as direct target for glucocorticoid-induced improvement of blood–brain barrier properties in a murine in vitro system, J. Physiol., 565, 475, 10.1113/jphysiol.2005.084038 Fujita, 2004, Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells, Mol. Endocrinol., 18, 2937, 10.1210/me.2004-0258 Guido, 2012, Estrogen receptor beta (ERbeta) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene, Cell Cycle, 11, 2911, 10.4161/cc.21336 Harke, 2008, Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element, Mol. Cell. Endocrinol., 295, 39, 10.1016/j.mce.2008.08.011 Kleinschnitz, 2011, Glucocorticoid insensitivity at the hypoxic blood–brain barrier can be reversed by inhibition of the proteasome, Stroke, 42, 1081, 10.1161/STROKEAHA.110.592238 Krishnan, 1994, Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells, J. Biol. Chem., 269, 15912, 10.1016/S0021-9258(17)40767-8 Kuiper, 1996, Cloning of a novel receptor expressed in rat prostate and ovary, Proc. Natl. Acad. Sci. USA, 93, 5925, 10.1073/pnas.93.12.5925 Kushner, 2000, Estrogen receptor pathways to AP-1, J. Steroid Biochem. Mol. Biol., 74, 311, 10.1016/S0960-0760(00)00108-4 Mangelsdorf, 1995, The nuclear receptor superfamily: the second decade, Cell, 83, 835, 10.1016/0092-8674(95)90199-X Morita, 1999, Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells, J. Cell Biol., 147, 185, 10.1083/jcb.147.1.185 Nilsson, 2011, Estrogen receptors: therapies targeted to receptor subtypes, Clin. Pharmacol. Ther., 89, 44, 10.1038/clpt.2010.226 Nitta, 2003, Size-selective loosening of the blood–brain barrier in claudin-5-deficient mice, J. Cell Biol., 161, 653, 10.1083/jcb.200302070 Ohtsuki, 2007, Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells, J. Cell. Physiol., 210, 81, 10.1002/jcp.20823 Pettersson, 2001, Role of estrogen receptor beta in estrogen action, Annu. Rev. Physiol., 63, 165, 10.1146/annurev.physiol.63.1.165 Porter, 1996, Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression, Mol. Endocrinol., 10, 1371 Qin, 1999, Transcriptional activation of insulin-like growth factor-binding protein-4 by 17beta-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes, Endocrinology, 140, 2501, 10.1210/endo.140.6.6751 Safe, 2004, Nuclear receptor-mediated transactivation through interaction with Sp proteins, Prog. Nucleic Acid Res. Mol. Biol., 77, 1, 10.1016/S0079-6603(04)77001-4 Safe, 2008, Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways, J. Mol. Endocrinol., 41, 263, 10.1677/JME-08-0103 Samudio, 2001, Transcriptional activation of deoxyribonucleic acid polymerase alpha gene expression in MCF-7 cells by 17 beta-estradiol, Endocrinology, 142, 1000, 10.1210/endo.142.3.8022 Scholz, 1998, Hormone-induced recruitment of Sp1 mediates estrogen activation of the rabbit uteroglobin gene in endometrial epithelium, J. Biol. Chem., 273, 4360, 10.1074/jbc.273.8.4360 Shibata, 1997, Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action, Recent Prog. Horm. Res., 52, 141 Stoner, 2000, Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins, J. Biol. Chem., 275, 22769, 10.1074/jbc.M002188200 Sun, 2005, Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins, Exp. Cell Res., 302, 96, 10.1016/j.yexcr.2004.08.015 Suzuki, 2010, Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex, J. Biol. Chem., 285, 13444, 10.1074/jbc.M109.062430 Taddei, 2008, Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5, Nat. Cell Biol., 10, 923, 10.1038/ncb1752 Thal, 2012, Volatile anesthetics influence blood–brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury, PLoS ONE, 7, e50752, 10.1371/journal.pone.0050752 Vyhlidal, 2000, Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site, J. Mol. Endocrinol., 24, 329, 10.1677/jme.0.0240329 Walter, 1985, Cloning of the human estrogen receptor cDNA, Proc. Natl. Acad. Sci USA, 82, 7889, 10.1073/pnas.82.23.7889 Xie, 1999, Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions, Endocrinology, 140, 219, 10.1210/endo.140.1.6394 Yuan, 2012, ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene, J. Biol. Chem., 287, 6582, 10.1074/jbc.M111.300236 Zhao, 2005, Mechanism of transcriptional regulation of LRP16 gene expression by 17-beta estradiol in MCF-7 human breast cancer cells, J. Mol. Endocrinol., 34, 77, 10.1677/jme.1.01628